A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factories of SD Biosensor, a South Korea's global in-vitro diagnostics company, during their visit to Korea. SD Biosensor introduced total diagnostic platforms for liver cancer, cervical cancer, tuberculosis, respiratory diseases, etc. SEOUL, South Korea , Nov.
20, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, stated that the National Center for Communicable Diseases, Mongolia (NCCD), visited SD Biosensor's Cheongju and Jeungpyeong Factories on November 8 and that the NCCD and SD Biosensor discussed cooperation measures to eradicate infectious diseases. According to the World Health Organization (WHO), Mongolia is one of the countries with the highest incidence rates of liver cancer, cervical cancer, tuberculosis, etc.
in the world. Among them, Mongolia's liver cancer incidence rate is the highest in the world, with Mongolian men's liver cancer incidence rate being 8 times as high as the global average and Mongolian women's liver cancer incidence rate being 16 times as hig h. Cervical cancer in Mongolia also has the highest incidence rate among Asian countries, and is the second most commonly detected cancer among Mongolian women, after liver cancer.
However, Mongolia's cervical cancer screening rate is very low compared to its incidence rate, with only 29.7% of women in Mongolia aged 1.
